Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)			1,233,853
Beginning Balance	$ (765,437)	$ (697,192)	$ (745,020)	$ (678,551)
Net loss	$ (20,375)	(19,632)	$ (40,792)	(38,273)
Ending Balance (in shares)	1,233,853		1,233,853
Ending Balance	$ (785,812)	$ (716,824)	$ (785,812)	$ (716,824)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Beginning Balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Ending Balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Ending Balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	81,323	81,323	81,323	81,323
Ending Balance	81,323	81,323	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(847,993)	(779,748)	(827,576)	(761,107)
Net loss	(20,375)	(19,632)	(40,792)	(38,273)
Ending Balance	$ (868,368)	$ (799,380)	$ (868,368)	$ (799,380)